SPECIFIC THROMBOPOIETIN CLONED AND SEQUENCED - WITH PERSONAL RETROSPECT AND CLINICAL PROSPECTS

Authors
KELEMEN E
Citation
E. Kelemen, SPECIFIC THROMBOPOIETIN CLONED AND SEQUENCED - WITH PERSONAL RETROSPECT AND CLINICAL PROSPECTS, Leukemia, 9(1), 1995, pp. 1-2
Citations number
20
Categorie Soggetti
Hematology,Oncology
Journal title
Leukemia → ACNP
ISSN journal
08876924
Volume
9
Issue
1
Year of publication
1995
Pages
1 - 2
Database
ISI
SICI code
0887-6924(1995)9:1<1:STCAS->2.0.ZU;2-3
Abstract
Description of some properties, and nomination of human thrombopoietin (TP) had already occurred in Hungary, in 1958. In 1994 five laborator ies (three in USA, one in France and one in Japan) independently publi shed clonal purification, sequencing, and chromosomal localization of TP. This breakthrough now approaches therapeutic use in humans.